IPSC vs IRM · rev $6.6M vs P/E 136, rev $6.15B
Century Therapeutics Inc (IPSC) versus Iron Mountain Incorporated (IRM) — a side-by-side from cached financials, not a winner call.
Century Therapeutics Inc (IPSC) is a biotechnology company listed on US.
Iron Mountain Incorporated (IRM) is a reit - specialty company listed on US.
Latest reported IPSC revenue for 2024-12-31 was $6.6M. Net income was -$126.6M. Revenue was up 194.8% from 2023-12-31 to 2024-12-31. IPSC currently screens at market cap $47.8M.
Latest reported IRM revenue for 2024-12-31 was $6.15B. Net income was $183.7M. Revenue was up 12.2% from 2023-12-31 to 2024-12-31. IRM currently screens at market cap $37.09B and trailing P/E 135.5.
IPSC currently screens at market cap $47.8M. IRM currently screens at market cap $37.09B and trailing P/E 135.5.
Not investment advice. Open the IPSC and IRM stock pages for the full models.
Not investment advice.